Quoin Pharmaceuticals, Ltd. Sponsored ADR QNRX
6.43
0.05
0.78%
as of 25 Sep
- Market cap
- $12.8M
- P/E
- 0.0×
Follow QNRX
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (575.73%) | (231.17%) | (141.59%) | (651.40%) |
+8 more TTM periods Free account |
|
| (178.77%) | (118.61%) | (87.56%) | (154.58%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(371.60%) | (170.10%) | (109.30%) | (5,491.66%) | |
Average Days of Receivables |
— | — | — | — | |
Free Cash Flow per Share |
(5.39) | (5.59) | (12.68) | (18.26) | |
Free Cash Flow |
(15.27) | (15.82) | (13.54) | (10.74) | |
| Other line items | |||||
Cash ROIC |
(103.67%) | (69.32%) | (42.49%) | (255.89%) | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.82 | 0.93 | 0.86 | 0.78 | |
Depreciation/Fixed assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(5.39) | (5.59) | (12.68) | (18.26) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates